Topics
Low-grade gliomas | Treatment | Clinical trials | External Beam Radiation Therapy
Home > Publications > Topics > Low-grade gliomas > Treatment > Clinical trials > External Beam Radiation Therapy
Baumert BG, Hegi ME, van den Bent MJ, von Deimling A, Gorlia T,
Hoang-Xuan K, Brandes AA, Sargos P, Taphoorn MJB, Vauleon E,
Philips C, Kros JM, Bady P, Wick W, Enting R, Reni M, Thiessen B,
Dhermain F, Bromberg JE, Jacob J, Reijneveld JC, Chinot O,
Gijtenbeek JMM, Rossiter JP, Balana C, Azevedo ALS, Clement PM,
Berghoff A, Tzuk-Shina T, Weller M, Nordal RA, Rees J, Lacombe DA,
Mason WP, Stupp R.
Temozolomide Versus
Radiotherapy as First-Line Therapy for Low-Grade Glioma: Mature
Results of a Randomized Phase III Trial (EORTC
22033-26033/NCIC-CTG/TROG/MRC-CTU).
J
Clin Oncol. 2026 Jul 2:JCO2502735. doi:
10.1200/JCO-25-02735. PMID:
42391581. Trial
registration ID: EORTC 22033-26033˰
ˍ
Kinslow CJ, Schiff D.
Mature Results
from EORTC 22033: Implications of Inferior Results with
Monotherapy for Grade 2 Gliomas.
Neuro
Oncol. 2026 Jul 20:noag162. doi:
10.1093/neuonc/noag162. PMID:
42477868. ˍ